Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 28, 2008

View Archived Issues

Recent patents describe new therapeutic agents for asthma and other respiratory disorders

New compounds for neurological disorders reported in recent patents

Recent patent literature discloses novel therapeutic agents for metabolic disorders

RN-18 inhibits viral replication by targeting a novel HIV-1 protein

Interim results from a first-in-human study with GSK-461364 in advanced solid tumor patients

Vidaza receives positive opinion from CHMP for treatment of MDS and AML

FDA accepts as complete for review Meda's NDA for azelastine antihistamine nasal spray

Biotie Therapies to acquire Elbion GmbH

Avid receives positive feedback from FDA regarding amyloid imaging compound AV-45

Schering-Plough's asenapine meets primary endpoint in schizophrenia relapse prevention trial

Noscira to initiate phase II NP-12 study in Alzheimer's disease

FDA approves LoSeasonique oral contraceptive

Ofatumumab demonstrates sustained efficacy in phase I/II rheumatoid arthritis trial

Early bactericidal activity seen with PA-824 in phase IIa tuberculosis study

Prokinetic effects of PF-00885706 evaluated in healthy volunteers

ALV-003 alters effects of gluten in celiac disease patients

Kowa submits NDA to FDA for pitavastatin

Merck Serono submits sNDA for Gonal-f in Japan for ovulation induction

Erbitux receives CHMP positive opinion for first-line use in head and neck cancer

Novartis launches Simulect in Japan for transplantation

Compugen launches viral peptides discovery platform for immune and inflammatory diseases

Omrix to resume enrollment in phase II clinical trial of Fibrin Pad

Stallergenes launches phase III Oralair Grasses trial in the U.S.

Kamada reports results from pivotal phase III trial of alpha-1 antitrypsin

Epigenomics presents update on PRESEPT clinical study of Septin 9 biomarker in colorectal cancer

Novel analgesics described in a recent University of Tennessee patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...